What is Cord Blood Banking?
Cord blood is rich in hematopoietic stem cells (HSCs). These stem cells are responsible for the formation of blood and immune systems, and they possess a remarkable capacity to transform into various types of cells and tissues. This unique quality makes cord blood an invaluable resource for medical treatments and therapies. Cord blood is a proven treatment for more than 80 diseases ranging from blood disorders, various types of cancers, inherited metabolic disorders, and immune system deficiencies. There are 100s of cord blood clinical trials actively recruiting for a range of disorders and conditions including neurological, autoimmune, cardiovascular, diabetic, genetic, metabolic, and orthopedic.
5-Compartment Storage Bag
What are Hematopoietic Stem Cells?
The Difference Between Cord Blood and Cord Tissue Banking
The primary intent of cord blood banking is to isolate and cryogenically preserve hematopoietic stem cells (HSCs) found in cord blood. Whereas the primary intent of cord tissue banking is to process and cryogenically preserve the cord tissue which contains mesenchymal stem cells (MSCs), growth factors, and cytokines.
Cord blood HSCs are FDA-approved to treat over 80 blood-related diseases and disorders. Treatments include various types of blood cancers and disorders and metabolic and immune disorders. In addition, there are 100s of ongoing clinical trials researching treatment options using HSCs for neurological disorders, traumatic brain injuries, cardiovascular disease, and autoimmune disorders.
Cord tissue is more versatile due to it containing MSCs, growth factors, and cytokines. It has potential applications that are distinct from applications using cord blood HSCs. There are 100s of clinical trials researching treatment options for Alzheimer’s disease, diabetes, Parkinson’s disease, and orthopedic diseases and disorders.
Together, cord blood and cord tissue could be the future of regenerative medicine. Many expectant parents choose to preserve both to provide the widest potential scope of treatment options for the future.
Americord CryoMaxx™ Cord Blood Processing
Americord’s CryoMaxx™ Cord Blood Processing unlocks the full potential of your baby’s cord blood. The process is based on the Rubenstein method to manually isolate a higher yield of cord blood hematopoietic stem cells (compared to automated processing) for our families. These HSCs are combined with a cryoprotectant to protect the cells during the controlled-rate freezing process to ensure their viability. The cord blood HSCs are stored in 5 compartment bags to ensure maximum flexibility to use the precise number of stem cells, while also having more options for multiple treatments.
Be Prepared for the Unknown.
You only have one chance to preserve your baby’s life-saving stem cells, and that’s the day they are born. Secure your family’s health by enrolling in stem cell banking today.
Cord blood stem cells are FDA-approved to treat over 80 blood-related diseases and disorders. This is not meant to be a comprehensive list, and new treatments are continuously being evaluated by researchers each year. To view a current list of all FDA-approved therapies, click here.
Non-Malignant Diseases & Congenital Conditions
Sickle Cell Disease
Severe Combined Immunodeficiency
Pure Red Cell Aplasia
Hunter Syndrome (MPS-II)
Hurler Syndrome (MPS-IH)
Neuronal Ceroid Lipofuscinosis
Clinical Trials Using Cord Blood
Today, there are 100s of clinical trials studying biotherapies using cord blood stem cells to treat neurologic, autoimmune, cardiovascular, genetic, metabolic, and orthopedic conditions.
Non-Blood Related Diseases
Hypoplastic Left Heart Syndrome
Acquired Hearing Loss
Type 1 Diabetes
Injuries & Orthopedic Conditions
Damaged Cartilage in Joints
Spinal Cord Injuries
Osteochondral Lesion of Talus
Questions About Cord Blood
Cord blood banking is a decision that many expectant parents consider, and it's important to weigh the potential benefits against the associated costs and uncertainties. The worth of cord blood banking depends on various factors, including your family's medical history, your values, and your future healthcare goals.
Cord blood banking is an excellent choice for families looking to be at the cutting edge of medical progress, as it enables them to proactively store a potential treatment option.
Cord blood banking is primarily used for storing the stem cells found in a newborn's umbilical cord blood. These stem cells have unique properties that make them valuable for medical purposes. Today, the stored cord blood can be used for 80 FDA-Approved treatments for illnesses and diseases ranging from Sickle Cell Disease to Leukemias. There are also hundreds of clinical trials ongoing each year.
At Americord, we understand that cost is an important consideration when making decisions about cord blood banking. Our pricing structure is designed to provide flexibility and affordability to our clients while ensuring the highest standards of service and quality. The cost of cord blood banking at Americord includes collection, processing, and storage. The total price starts at $3,799 and payment plans start as low as $131/mo.
Your baby's cord blood holds the potential to benefit both immediate family members, such as parents and siblings, as well as second-degree family members, like aunts, uncles, and grandparents. This means that not only can it provide essential support to your closest loved ones, but also offer a potential valuable resource for relatives beyond your immediate family circle.
Cord blood can be stored for an extended duration, making it a valuable asset for your family's future health needs. The preservation of cord blood is typically intended for the long term, and it can be stored for decades or even longer. Americord offers cord blood storage from 20 years to lifetime (78 years). This extended storage period ensures that the stem cells remain viable and effective for potential treatments, should the need arise in the years to come.